The equity research team at US financial services firm Morningstar has published the Annual Drug Pipeline report, which looks at the large-cap biopharma groups 20 January 2022
The US Centers for Disease Control and Prevention (CDC) has endorsed updated recommendations made by the Advisory Committee on Immunization Practices (ACIP) for 17 December 2021
In August 2020, Russia approved its homegrown coronavirus vaccine Sputnik V, months ahead of rival programs in the west. Episode 8 of The Pharma Letter Podcast 14 December 2021
Could the Build Back Better social spending bill deliver on the promise that previous US administrations have failed to, by passing new federal legislation that 10 December 2021
The Institute for Clinical and Economic Review (ICER) regularly calls out drugmakers in certain therapy areas for introducing drugs to the market at prices that 16 November 2021
Groups campaigning for lower US drug prices reacted with exasperation last week when President Joe Biden announced the framework for his Build Back Better Agend 1 November 2021
US President Joe Biden was never going to please everyone in announcing the framework for his Build Back Better Agenda and Bipartisan Infrastructure Bill, but t 29 October 2021
Since Donald Trump’s 2018 “American Patients First” plan, and long before, the issue of drug pricing in the USA has been both a lightning rod for strong opinion 12 October 2021
A stern letter has been written to the US Food and Drug Administration (FDA) by the chairs of two US congressional committees demanding answers in relation to t 3 September 2021
All signs point to an M&A boom in late 2021 and throughout 2022. In this episode, Lance Minor, principal and national co-leader of the life sciences practice at 1 September 2021
While people in many parts of the world wait in the hope of receiving their first shot of a COVID-19 vaccine, Americans are to be offered their third dose in an 19 August 2021
The controversy over the approval of Alzheimer’s med Aduhelm (aducanumab) has deepened, as the acting head of the US Food and Drug Administration called for an 12 July 2021
The US Government has announced it will invest more than $3 billion to boost discovery and development of new antiviral medicines for the novel coronavirus. 18 June 2021
The US Government has purchased an additional 200 million doses of the coronavirus vaccine developed by Moderna, in case boosters are needed. 17 June 2021
The US Government has committed to buying 500 million doses of Comirnaty, the vaccine provided by Pfizer and BioNTech, for lower-income countries. 10 June 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.